Disclaimer / Disclosures

 

Address: 1825 NW Corporate Blvd.Suite #110 Boca Raton FL. 33431

Email:corp@otcprgroup.com

Join Our Free Newsletter for the Latest Investor Relation Marketing Tips!!!

Summary of Disclaimer / Disclosures

  • You should review the entirety of the following Statements & Policies, which include important information not included in this Summary of Disclosures. You should not rely solely on this summary. By accessing www.otcprgroup.com (hereinafter referred to as “OTC PR Group,” “we,” “us,” or “our”) website, you agree that you have reviewed and agree to the following Statements & Policies. If you do not agree to these Statements & Policies, you may not use the OTC PR Group website. OTC PR Group provides readers with information regarding publicly traded companies that have retained OTC PR Group to provide advertising, news and public relations services on their behalf. OTC PR Group receives compensation from the companies in the form of cash and/or securities in the companies. OTC PR Group is neither an investment adviser nor a broker-dealer. The information presented in the OTC PR Group website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. None of the information provided through this website constitutes a recommendation. Please consult with an independent investment adviser or other financial adviser before making an investment decision. The opinions and analysis included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith, but no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice. OTC PR Group and its owners, officers, directors, employees and affiliates may own, or may buy and sell, securities of companies profiled on the OTC PR Group website at any time before, during, or after distribution of information on the companies by OTC PR Group.

 

Safe Harbor Statement

This website includes forward-looking statements pertaining to future anticipated plans, performance and development of the companies on whose behalf we disseminate information. Any statements on this website that are not statements of historical fact should be considered forward-looking statements. These forward-looking statements generally can be identified by phrases such as “believes,” “expects,” “anticipates,” “foresees,” “forecasts,” “estimates,” “intends,” or other words or phrases of similar import. Similarly, statements in this website that describe a company’s business strategy; outlook, objectives, plans, intentions or goals also are forward-looking statements. All such forward–looking statements are subject to certain risks and uncertainties that could cause actual results to differ materially from those in such forward-looking statements.

Terms of Use

By accessing OTC PR Group website, you signify your agreement to these Statements & Policies. If you do not agree to these Statements & Policies, you may not use the OTC PR Group website. We reserve the right, at our sole discretion, to change, modify, add or delete portions of these Statements & Policies at any time. The OTC PR Group website may contain many links to other websites, including paid advertisements, whose content is not managed by OTC PR Group. We do not endorse, nor are we responsible for, any of the content of those external websites.

Privacy Statement

This notice applies to all information collected or submitted on the OTC PR Group website. On some pages, you can make requests and register to receive materials. The types of personal information collected at these pages are: Name, Company, Title, Address, Email address, Phone number(s)

The Way We Use Information

We use the information you provide about yourself when responding to your requests for specific information. We occasionally share this information with outside parties we believe you would find of interest. Such parties for this service may compensate us. We use return email addresses to answer the email we receive. You can register with our website if you would like to receive our periodic mailings as well as updates on our new products and services. Information you submit on our website will not be used for this purpose unless you fill out the registration form. We use non-identifying and aggregate information to better design our website and to share with advertisers. For example, we may tell an advertiser that X number of individuals visited a certain area on our website, or that Y number of men and Z number of women filled out our registration form. Finally, we never use or share the personally identifiable information provided to us online in ways unrelated to those described above without also providing you an opportunity to opt-out or otherwise prohibit such unrelated uses. To opt out of our newsletter, please go to corp@otcprgroup.com

Copyright Notice

All rights, including copyright, in the content of the OTC PR Group website are owned or controlled for these purposes by OTC PR Group.In accessing the OTC PR Group website, you agree that you may only download and/or view the content for your own personal, non-commercial use.Except where expressly stated otherwise, without the prior written permission of OTC PR Group, you are not permitted to copy, broadcast, download, store (in any medium), transmit, show or play in public, adapt or change in any way the content of the OTC PR Group website for any other purpose whatsoever.

Our Commitment To Data Security

To prevent unauthorized access, maintain data accuracy, and ensure the correct use of information, we have put in place what we believe are appropriate physical, electronic, and managerial procedures to safeguard and secure the information we collect online. However, we make no guarantees or representations that such procedures will be effective and that all information will remain secure under all circumstances.

OTC PR Group “Spotlight” Disclaimer

OTC PR Group is not a registered investment advisor. The information contained on this site is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented on this recorded line is provided for informational purposes only and is not to be treated as advice to make any specific investment. Please consult with an independent investment advisor before making an investment decision. Neither OTC PR Group nor its officers, directors, partners, employees, consultants nor anyone involved in this site is a registered investment adviser or broker/dealer and none of the foregoing make any recommendation that the purchase of securities of any company profiled on this site is suitable or advisable for any person or that an investment in such securities will be profitable. Past performance of profiled securities is not indicative of future results. Companies profiled on this site line may lack an active trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Anyone investing in these companies should be able and prepared to bear a loss of his or her entire investment.

 

Educational Resources Disclaimer

Online Broker Reviews are provided for general information purposes only and should not be considered an individualized recommendation or advice. OTC PR Group DOES NOT receive any compensation from any of the online brokerage firms reviewed in this Educational Resources – Online Broker Reviews.

Email and Instant Message Policy Information Regarding Securities and Market Data. OTC PR Group does not guarantee any information regarding securities issues and market data contained in an email to or from its employees, agents, or affiliates. Email and Instant Message (IM) Security. OTC PR Group is not responsible for any damages resulting from a third party intercepting or otherwise obtaining an email, or the information contained within an email, sent to or from OTC PR Group, its employees, agents, or affiliates. For your protection, do not include account numbers, social security numbers, credit card numbers, passwords or any other non-public information in your email or IM. Monitoring and Confidentiality of Email and Instant Messaging (IM). OTC PR Group may monitor email and IM communications addressed to the firm and any of its employees. OTC PR Group reserves the right to monitor such communications and does not guarantee the confidentiality of any transmission.

OTC PR Group Rating Disclaimer OTC PR Group strives to ensure that all content and information published at this web site is current and accurate. The information and ratings at OTC PR Group does not in any way constitute legal or professional advice and OTC PR Group cannot be held liable for actions arising from its use. These ratings are based on OTC PR Group opinion ONLY and these ratings are NOT a recommendation to BUY and or SELL any SEC regulated public company. In addition, OTC PR Group cannot be held responsible for the contents of any externally linked pages. Reference within this site to any specific commercial or non-commercial company, newsletter, product, process, or service by trade name, trademark, or otherwise does not constitute or imply an endorsement, recommendation, or favoring by OTC PR Group.

Compensation Disclosure

The OTC PR Group website provides readers with information regarding publicly traded companies that have retained OTC PR Group to provide advertising, news and public relations services on their behalf. OTC PR Group receives compensation from the companies in the form of cash and/or securities in the companies. Such compensation, especially compensation in the form of securities, may create an actual or potential conflict of interest. In addition, to the extent that parties, including the companies discussed, investors or others, further disseminate content or other statements provided by OTC PR Group, such parties operate outside of OTC PR Group control. Appropriate disclaimers or other disclosures may not accompany such further dissemination, and OTC PR Group assumes no responsibility for any such statements or dissemination.

Because OTC PR Group receives compensation for disseminating information; we may have a conflict of interest in terms of disseminating negative information about the companies that retain us. Readers should consider this in reaching their independent decision as to how to use the information contained in the OTC PR Group website.

It is the practice of OTC PR Group to sell all securities received as compensation upon the expiration of the applicable holding period set forth in Rule 144 under the Securities Act of 1933 (Rule 144), notwithstanding the fact that OTC PR Group may be advertising or distributing materials on such securities and their issuers at the time of the sale of such securities. More generally, OTC PR Group may sell any securities that it holds at any time that it legally may do so, as it deems appropriate.

In addition, writers and editors who provide or review content contained on OTC PR Group website may buy, sell or maintain positions in securities of the companies discussed on OTC PR Group website. Such trading, which necessarily reflects an individual’s personal resources and financial condition, may be inconsistent with statements on OTC PR Group website.

AEMD:First Equity Group Inc. has received $12,500 from AEMD for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

BCLI:First Equity Group Inc. has received 100,000 Restricted 144 Shares of Common Stock of BCLI for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

EARK:First Equity Group Inc. has received $5,000 and 30,000 Restricted 144 Shares of Common Stock of Magnolia Solar Inc. for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

GLFH: First Equity Group Inc. has received $2,500 from GLFH for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

ISCO: First Equity Group Inc. has received $3,500 from ISCO for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

MJNA:First Equity Group Inc. has received $5,000 and 125,000 Restricted 144 Shares of Common Stock of MJNA for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

GATA:First Equity Group Inc. has received $5,000 from GATA for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

SWRM:First Equity Group Inc. has received $10,000 from SWRM for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

PKTX:First Equity Group Inc. has received 500,000 Restricted 144 Shares of Common Stock of PKTX for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

PSID:First Equity Group Inc. has received $3,000 and 1,550,000 Restricted 144 Shares of Common Stock of PSID for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

RJDG:First Equity Group Inc. has received $15,000 from RJDG and expects to receive additional $5,000 per month for 6 months for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

TPSC:First Equity Group Inc. has received $2,500 from TPSC for advertising, branding, marketing, investor relations and social media services provided by First Equity Group Inc and affiliate brands.

Disclaimer

Neither OTC PR Group nor its officers, directors, partners, employees, consultants, nor anyone involved in the publication of this website, is a registered investment adviser or broker/dealer and none of the foregoing make any recommendation that the purchase of securities of any company profiled in the OTC PR Group website is suitable or advisable for any person or that an investment in such securities will be profitable. The information contained in the OTC PR Group website is not intended to be, and shall not constitute, an offer to sell nor the solicitation of any offer to buy any security. The information presented in the OTC PR Group website is provided for informational purposes only and is not to be treated as advice or a recommendation to make any specific investment. Please consult with an independent investment adviser before making an investment decision.

The opinions and analysis included in this website are based on factual information obtained from public filings and other sources deemed to be reliable and are provided “as is” in good faith, but no representation or warranty, expressed, implied, or statutory, is made as to the accuracy or completeness of such information, which may be subject to change without notice. OTC PR Group shall not be liable for any errors or any actions taken in reliance thereon. Statements of opinion and belief are those of the authors and/or editors of this website, and are based solely upon the information possessed by such authors and/or editors; no inference should be drawn that OTC PR Group or such authors or editors have any special or greater knowledge about the companies profiled or any particular expertise in the industries or markets in which the profiled companies operate and compete.

Factual information on this website is obtained from public filings and other sources deemed to be reliable; however, OTC PR Group takes no responsibility for verifying the accuracy of such information and makes no representation that such information is accurate or complete. Certain statements included in this website may be forward-looking statements based on current expectations. OTC PR Group makes no representation and provides no assurance or guaranty that such forward -looking statements will prove to be accurate. Persons using the OTC PR Group website are urged to consult with independent financial advisers with respect to an investment in any company profiled herein. Investors should independently verify information provided in the OTC PR Group website by completing their own due diligence on any company in which they are contemplating an investment and review a complete information package on that company, which should include, but not be limited to, the company’s annual reports, quarterly reports, press releases, and regulatory filings.

Past performance of profiled securities is not indicative of future results. Companies profiled in this website may lack an active trading market for their securities and investing in such securities is highly speculative and carries a high degree of risk. Anyone investing in these companies should be able and prepared to bear a loss of his or her entire investment. The information on this website is not designed to be used as the sole basis for an investment decision. Persons using the OTC PR Group website should confirm to their own satisfaction the veracity of any information prior to entering into any investment. The decision to buy or sell any security of a company that may be featured by OTC PR Group is done purely at the reader’s own risk. Under no circumstances will OTC PR Group owners, officers, directors, partners, employees, consultants or other persons involved in the publication of this website be held liable for any losses incurred by the use of information contained in this website.

OTC PR Group and its owners, officers, directors, employees and affiliates may own, or may buy and sell, securities of companies profiled in this website at any time before, during, or after distribution of information on the companies by OTC PR Group. OTC PR Group and its employees and affiliates may profit in the event the shares of the companies increase in value. Such securities may be sold from time to time even after OTC PR Group has distributed positive information regarding the companies. OTC PR Group does not guarantee that it will purchase the securities of profiled companies. OTC PR Group has no obligation to inform readers of its trading activities or the trading activities of any of its employees and/or affiliates.

OTC PR Group from time to time enters into agreements to purchase securities of publicly traded companies to provide financing to these companies.

Risk Warnings

The content published on this website is intended for and only to be used for reference purposes and is neither an offer nor a solicitation to purchase or sell any security or instrument or to participate in any particular trading strategy. None of the information provided through this website constitutes a recommendation that any investment or trading strategy is suitable for any person. Persons should consult with their financial advisers before making any investment decisions.

THERE CAN BE NO ASSURANCE THAT THE CONTENT PUBLISHED ON THIS SITE IS ACCURATE OR WITHOUT ERROR. ANY PERSON WHO MAKES USE OF SUCH CONTENT EXPRESSLY ASSUMES ALL RISKS FROM USING THE CONTENT. In particular, OTC PR Group does not guarantee its reviews, and is not responsible for confirming, the accuracy of issuer documents and information submitted for inclusion on this site. The issuer and its management are primarily responsible for the accuracy of any information regarding the issuer provided on this site. INVESTORS ARE STRONGLY ADVISED TO CONFIRM THE ACCURACY OF ANY INFORMATION OBTAINED FROM THIS SITE PRIOR TO MAKING ANY INVESTMENT DECISION.

Because many securities traded over-the-counter (OTC) are relatively illiquid, or “thinly traded,” which tends to increase volatility in market prices, an investment in an OTC security involves a high degree of risk. These speculative and illiquid securities are often difficult for investors to buy or sell without significantly affecting the quoted price. It should be noted that the liquidation of a position in an OTC security might not even be possible within a reasonable period of time.

Dependable information regarding issuers of OTC securities, their prospects, or the risks associated with the business of any particular issuer or an investment in the issuer’s securities may not be available. For this reason, it may be difficult to properly value an investment in an OTC security or accurately determine the risks involved with investing in such a security.

Issuers of OTC securities quoted on the OTC Link system are not required to provide any kind of information to investors. While many issuers register OTC securities with the Securities and Exchange Commission (SEC) and regularly provide reports to investors in connection with such registration, they are not required to continue such registration or regularly provide such reports because their securities are quoted on OTC Link. Securities may continue to be quoted on the OTC Link system if issuers are delinquent in their reporting obligation to the SEC or other federal or state regulatory agencies. Quotation of a security on the OTC Link system or the Yellow Sheets does not in itself create any ongoing filing or reporting obligations with the SEC for any issuer. In fact, issuers may not even be aware that their securities are quoted on the OTC Link system.

Third-Party Content

The OTC PR Group website may contain articles and other content submitted by third parties, including, but not limited to, articles submitted through the OTC PR Group Premium Partnership Program. The opinions and other statements expressed by such third parties are theirs alone and do not express the views and opinions of OTC PR Group or its affiliates. Content created by third parties is the sole responsibility of such third parties and its accuracy and completeness are not endorsed or guaranteed by OTC PR Group. You acknowledge that by providing you with the ability to view third-party content through our site, OTC PR Group is not undertaking any obligation or liability relating to such third-party content. OTC PR Group and its affiliates, successors, assigns, officers, directors, partners and employees assume no responsibility or liability that may arise from the third party content, including, but not limited to, claims for defamation, libel, slander, infringement, invasion of OTC PR Group privacy and publicity rights, fraud, or misrepresentation. Notwithstanding the foregoing, OTC PR Group reserves the right to remove third-party content at any time in its sole discretion.

 

2017 OTC PR Group, All Rights Reserved
Menu Title